dpp4i and glp 1 agonist GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Role of DPP-4 Inhibitors in
Description
Consistent with previous studies, cotadutide outperformed GLP-1 alone (40 nmol/kg/day liraglutide) in achieving maximal weight loss in obese mice, and this was attributed to the increased energy expenditure (77)

Nausea can become a cycle: low appetite leads to low intake, low intake leads to weakness or queasiness, and then food feels even harder to tolerate

Minis E, Stanford FC, Mahalingaiah S

[DOI] [PMC free article] [PubMed] [Google Scholar] 48.Bluher M, Rosenstock J, Hoefler J, Manuel R, Hennige AM

Yamaguchi, E., Yasoshima, Y

Primary Care of Clear Lake offers Semaglutide GLP-1 for weight reduction as an efficient therapy option for treating obesity through lower calorie intake and appetite control
